1-1 of 1
Masaki Abe, PhD
Close
Sort by
Journal Articles

YM477, a Novel Orally-Active Thrombopoietin Receptor Agonist.

Ken-ichi Suzuki, PhD, Masaki Abe, PhD, Mari Fukushima-Shintani, Keizo Sugasawa, PhD, Fukushi Hirayama, PhD, Tomihisa Kawasaki, PhD, Hidefumi Hiramatsu, MD, PhD, Tatsutoshi Nakahata, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 2298.
https://doi.org/10.1182/blood.V106.11.2298.2298
Published: 2005